Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The goal of this research is to evaluate and compare the effectiveness of Systane® versus
Optive™ on aqueous tear film stability in patients with a diagnosis of Dry Eye Syndrome and
to determine the possible application for this product in the future. Systane® is marketed as
over-the-counter tear lubricating therapy in the United States under the FDA monograph.